Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NURSECARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   6.1% 6.4% 6.2% 7.8% 12.8% 9.4% 15.9% 15.9%   Credit score (0-100)   40 37 36 31 17 26 12 12   Credit rating   BBB BBB BBB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   1,143 0 0 0 0 0 0 0   Gross profit   719 654 1,290 1,615 1,124 1,717 0.0 0.0   EBITDA   144 -59.6 240 246 -306 29.8 0.0 0.0   EBIT   144 -59.6 240 246 -306 29.8 0.0 0.0   Pre-tax profit (PTP)   112.2 -6.0 1,080.9 89.1 -316.2 10.0 0.0 0.0   Net earnings   85.7 -7.1 840.2 66.2 -247.7 4.7 0.0 0.0   Pre-tax profit without non-rec. items   112 -6.0 1,081 89.1 -316 10.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   166 159 999 203 -44.9 -40.1 -176 -176   Interest-bearing liabilities   293 322 457 698 379 109 176 176   Balance sheet total (assets)   493 601 1,892 2,888 455 2,056 0.0 0.0   Net Debt   136 101 -1,088 581 331 42.3 176 176     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   1,143 0 0 0 0 0 0 0   Net sales growth   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   719 654 1,290 1,615 1,124 1,717 0.0 0.0   Gross profit growth   8.0% -9.1% 97.4% 25.2% -30.4% 52.8% -100.0% 0.0%   Employees   0 2 2 2 3 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 50.0% -66.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   493 601 1,892 2,888 455 2,056 0 0   Balance sheet change%   11.1% 22.0% 214.6% 52.6% -84.2% 351.5% -100.0% 0.0%   Added value   144.4 -59.6 240.4 245.6 -306.3 29.8 0.0 0.0   Added value %   12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.1% -9.1% 18.6% 15.2% -27.3% 1.7% 0.0% 0.0%   Net Earnings %   7.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   7.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   9.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   38.9% 10.9% 99.9% 28.3% -16.2% 2.6% 0.0% 0.0%   ROI %   47.2% 12.7% 128.6% 57.4% -42.9% 14.1% 0.0% 0.0%   ROE %   69.8% -4.4% 145.2% 11.0% -75.3% 0.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   33.6% 26.4% 52.8% 7.0% -9.0% -1.9% -100.0% -100.0%   Relative indebtedness %   28.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   14.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   94.3% -170.2% -452.5% 236.5% -108.2% 142.1% 0.0% 0.0%   Gearing %   176.7% 203.4% 45.8% 344.2% -843.5% -272.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   26.6% 21.4% 42.2% 101.7% 7.7% 10.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.5 1.4 2.3 0.5 0.9 0.1 0.0 0.0   Current Ratio   1.5 1.4 2.3 1.1 0.9 1.0 0.0 0.0   Cash and cash equivalent   156.6 220.9 1,544.6 117.6 47.2 67.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   43.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9.3 -61.3 -490.1 271.5 -54.5 -42.1 -88.1 -88.1   Net working capital %   0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -30 120 123 -102 30 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -30 120 123 -102 30 0 0   EBIT / employee   0 -30 120 123 -102 30 0 0   Net earnings / employee   0 -4 420 33 -83 5 0 0